[1]
|
White, H., Boden-Albala, B., Wang, C., et al. (2005) Ischemic Stroke Subtype Incidence among Whites, Blacks, and Hispanics. Circulation, 111, 1327-1331. https://doi.org/10.1161/01.CIR.0000157736.19739.D0
|
[2]
|
Wong, L.K.S. (2006) Global Burden of Intracranial Atherosclerosis. International Journal of Stroke, 1, 158-159. https://doi.org/10.1111/j.1747-4949.2006.00045.x
|
[3]
|
Wang, Y., Zhao, X., Liu, L., et al. (2014) Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in China: The Chinese Intracranial Atherosclerosis (CICAS) Study. Stroke, 45, 663-669. https://doi.org/10.1161/STROKEAHA.113.003508
|
[4]
|
Sangha, R.S., Naidech, A.M., Corado, C., et al. (2017) Challenges in the Medical Management of Symptomatic Intracranial Stenosis in an Urban Setting. Stroke, 48, 2158-2163. https://doi.org/10.1161/STROKEAHA.116.016254
|
[5]
|
Song, X., Li, S., Du, H., et al. (2022) Association of Plaque Morphology with Stroke Mechanism in Patients with Symptomatic Posterior Circulation ICAD. Neurology, 99, e2708-e2717. https://doi.org/10.1212/WNL.0000000000201299
|
[6]
|
Dubow, J.S., Salamon, E., Greenberg, E., et al. (2014) Mechanism of Acute Ischemic Stroke in Patients with Severe Middle Cerebral Artery Atherosclerotic Disease. Journal of Stroke and Cerebrovascular Diseases, 23, 1191-1194. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.10.015
|
[7]
|
Wabnitz, A.M., Derdeyn, C.P., Fiorella, D.J., et al. (2019) Hemodynamic Markers in the Anterior Circulation as Predictors of Recurrent Stroke in Patients with Intracranial Stenosis. Stroke, 50, 143-147. https://doi.org/10.1161/STROKEAHA.118.020840
|
[8]
|
Prabhakaran, S., Liebeskind, D.S., Cotsonis, G., et al. (2021) Predictors of Early Infarct Recurrence in Patients with Symptomatic Intracranial Atherosclerotic Disease. Stroke, 52, 1961-1966. https://doi.org/10.1161/STROKEAHA.120.032676
|
[9]
|
Amin-Hanjani, S., Pandey, D.K., Rose-Finnell, L., et al. (2016) Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease. JAMA Neurology, 73, 178-185. https://doi.org/10.1001/jamaneurol.2015.3772
|
[10]
|
Alexander, M.J. and Yu, W. (2023) Intracranial Atherosclerosis Update for Neurointerventionalists. Journal of NeuroInterventional Surgery, 16, 522-528. https://doi.org/10.1136/jnis-2022-019628
|
[11]
|
Prabhakaran, S., Wells, K.R., Jhaveri, M.D., et al. (2011) Hemodynamic Changes Following Wingspan Stent Placement—A Quantitative Magnetic Resonance Angiography Study. Journal of Neuroimaging, 21, e109-e113. https://doi.org/10.1111/j.1552-6569.2009.00425.x
|
[12]
|
Guppy, K.H., Charbel, F.T., Corsten, L.A., et al. (2002) Hemodynamic Evaluation of Basilar and Vertebral Artery Angioplasty. Neurosurgery, 51, 327-334. https://doi.org/10.1097/00006123-200208000-00006
|
[13]
|
Sundt, T.M., Smith, H.C., Campbell, J.K., et al. (1980) Transluminal Angioplasty for Basilar Artery Stenosis. Mayo Clinic Proceedings, 55, 673-680.
|
[14]
|
Clark, W.M., Barnwell, S.L., Nesbit, G., et al. (1995) Safety and Efficacy of Percutaneous Transluminal Angioplasty for Intracranial Atherosclerotic Stenosis. Stroke, 26, 1200-1204. https://doi.org/10.1161/01.STR.26.7.1200
|
[15]
|
Mori, T., Mori, K., Fukuoka, M., et al. (1997) Percutaneous Transluminal Cerebral Angioplasty: Serial Angiographic Follow-Up after Successful Dilatation. Neuroradiology, 39, 111-116. https://doi.org/10.1007/s002340050376
|
[16]
|
Serruys, P.W., De Jaegere, P., Kiemeneij, F., et al. (1994) A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease. The New England Journal of Medicine, 331, 489-495. https://doi.org/10.1056/NEJM199408253310801
|
[17]
|
Fiorella, D. and Woo, H.H. (2007) Emerging Endovascular Therapies for Symptomatic Intracranial Atherosclerotic Disease. Stroke, 38, 2391-2396. https://doi.org/10.1161/STROKEAHA.107.482752
|
[18]
|
Derdeyn, C.P., Chimowitz, M.I., Lynn, M.J., et al. (2014) Aggressive Medical Treatment with or without Stenting in High-Risk Patients with Intracranial Artery Stenosis (SAMMPRIS): the Final Results of a Randomised Trial. Lancet, 383, 333-341.
|
[19]
|
Zaidat, O.O., Fitzsimmons, B.F., Woodward, B.K., et al. (2015) Effect of A Balloon-Expandable Intracranial Stent vs Medical Therapy on Risk of Stroke in Patients with Symptomatic Intracranial Stenosis: The VISSIT Randomized Clinical Trial. JAMA, 313, 1240-1248. https://doi.org/10.1001/jama.2015.1693
|
[20]
|
Fiorella, D., Derdeyn, C.P., Lynn, M.J., et al. (2012) Detailed Analysis of Periprocedural Strokes in Patients Undergoing Intracranial Stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke, 43, 2682-2688. https://doi.org/10.1161/STROKEAHA.112.661173
|
[21]
|
Miao, Z., Jiang, L., Wu, H., et al. (2012) Randomized Controlled Trial of Symptomatic Middle Cerebral Artery Stenosis: Endovascular versus Medical Therapy in A Chinese Population. Stroke, 43, 3284-3290. https://doi.org/10.1161/STROKEAHA.112.662270
|
[22]
|
Gao, P., Wang, T., Wang, D., et al. (2022) Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients with Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial. JAMA, 328, 534-542. https://doi.org/10.1001/jama.2022.12000
|
[23]
|
Zaidat, O.O., Klucznik, R., Alexander, M.J., et al. (2008) The NIH Registry on Use of the Wingspan Stent for Symptomatic 70-99% Intracranial Arterial Stenosis. Neurology, 70, 1518-1524. https://doi.org/10.1212/01.wnl.0000306308.08229.a3
|
[24]
|
Fiorella, D., Levy, E.I., Turk, A.S., et al. (2007) US Multicenter Experience with the Wingspan Stent System for the Treatment of Intracranial Atheromatous Disease: Periprocedural Results. Stroke, 38, 881-887. https://doi.org/10.1161/01.STR.0000257963.65728.e8
|
[25]
|
Chimowitz, M.I., Lynn, M.J., Derdeyn, C.P., et al. (2011) Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis. The New England Journal of Medicine, 365, 993-1003. https://doi.org/10.1056/NEJMc1111906
|
[26]
|
Alexander, M.J., Zauner, A., Chaloupka, J.C., et al. (2019) WEAVE Trial: Final Results in 152 On-Label Patients. Stroke, 50, 889-894. https://doi.org/10.1161/STROKEAHA.118.023996
|
[27]
|
Jiang, W.J., Xu, X.T., Jin, M., et al. (2007) Apollo Stent for Symptomatic Atherosclerotic Intracranial Stenosis: Study Results. American Journal of Neuroradiology, 28, 830-834.
|
[28]
|
The SSYLVIA Study Investigators (2004) Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): Study Results. Stroke, 35, 1388-1392. https://doi.org/10.1161/01.STR.0000128708.86762.d6
|
[29]
|
Von Schoenfeldt, P., Krützelmann, A., Bußmeyer, M., et al. (2015) Elective Treatment of Intracranial Stenosis with the Balloon-Expandable Pharos Vitesse Stent: 30-Day Stroke Rate and Complications. Journal of Neurointerventional Surgery, 7, 188-193. https://doi.org/10.1136/neurintsurg-2013-011019
|
[30]
|
Möhlenbruch, M.A., Pfaff, J., Herweh, C., et al. (2016) One-Pass Endovascular Treatment of Intracranial Atherosclerotic Stenosis with a Novel PTA Balloon and Self-Expanding Microstent. Neuroradiology, 58, 893-899. https://doi.org/10.1007/s00234-016-1716-8
|
[31]
|
Hassan, A.E., Khalil, M., Desai, S., et al. (2023) Resolute Onyx Stent More Effective than Wingspan Stent at Preventing Procedural Complications and Long-Term Restenosis. Interventional Neuroradiology, 29, 691-695. https://doi.org/10.1177/15910199221104633
|
[32]
|
White, T.G., Shah Koul, K.A., et al. (2024) The Resolute Onyx Drug Eluting Stent for Neurointervention: A Technical Series. Interventional Neuroradiology, 30, 14-21. https://doi.org/10.1177/15910199221084398
|
[33]
|
Htay, T. and Liu, M.W. (2005) Drug-Eluting Stent: A Review and Update. Vascular Health and Risk Management, 1, 263-276. https://doi.org/10.2147/vhrm.2005.1.4.263
|
[34]
|
Derdeyn, C.P., Fiorella, D., Lynn, M.J., et al. (2017) Nonprocedural Symptomatic Infarction and In-Stent Restenosis after Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis). Stroke, 48, 1501-1506. https://doi.org/10.1161/STROKEAHA.116.014537
|
[35]
|
Aoki, J. and Tanabe, K. (2021) Mechanisms of Drug-Eluting Stent Restenosis. Cardiovascular Intervention and Therapeutics, 36, 23-29. https://doi.org/10.1007/s12928-020-00734-7
|
[36]
|
Wessely, R. (2010) New Drug-Eluting Stent Concepts. Nature Reviews Cardiology, 7, 194-203. https://doi.org/10.1038/nrcardio.2010.14
|
[37]
|
McFadden, E.P., Stabile, E., Regar, E., et al. (2004) Late Thrombosis in Drug-Eluting Coronary Stents after Discontinuation of Antiplatelet Therapy. Lancet, 364, 1519-1521. https://doi.org/10.1016/S0140-6736(04)17275-9
|
[38]
|
Chen, Y.W., Smith, M.L., Sheets, M., et al. (2007) Zotarolimus, A Novel Sirolimus Analogue with Potent Anti-Proliferative Activity on Coronary Smooth Muscle Cells and Reduced Potential for Systemic Immunosuppression. Journal of Cardiovascular Pharmacology, 49, 228-235. https://doi.org/10.1097/FJC.0b013e3180325b0a
|
[39]
|
Garcia-Touchard, A., Burke, S.E., Toner, J.L., et al. (2006) Zotarolimus-Eluting Stents Reduce Experimental Coronary Artery Neointimal Hyperplasia after 4 Weeks. European Heart Journal, 27, 988-993. https://doi.org/10.1093/eurheartj/ehi752
|
[40]
|
Iqbal, J., Gunn, J. and Serruys, P.W. (2013) Coronary Stents: Historical Development, Current Status and Future Directions. British Medical Bulletin, 106: 193-211. https://doi.org/10.1093/bmb/ldt009
|
[41]
|
Windecker, S., Latib, A., Kedhi, E., et al. (2020) Polymer-Based or Polymer-Free Stents in Patients at High Bleeding Risk. The New England Journal of Medicine, 382, 1208-1218. https://doi.org/10.1056/NEJMoa1910021
|
[42]
|
Qureshi, A.I., Kirmani, J.F., Hussein, H.M., et al. (2006) Early and Intermediate-Term Outcomes with Drug-Eluting Stents in High-Risk Patients with Symptomatic Intracranial Stenosis. Neurosurgery, 59, 1044-1051. https://doi.org/10.1227/01.NEU.0000245593.54204.99
|
[43]
|
Abou-Chebl, A., Bashir, Q. and Yadav, J.S. (2005) Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis: Initial Experience and Midterm Angiographic Follow-Up. Stroke, 36, e165-e168. https://doi.org/10.1161/01.STR.0000190893.74268.fd
|
[44]
|
Ye, G., Yin, X., Yang, X., et al. (2019) Efficacy and Safety of Drug-Eluting Stent for the Intracranial Atherosclerotic Disease: A Systematic Review and Meta-Analysis. Journal of Clinical Neuroscience, 59, 112-118. https://doi.org/10.1016/j.jocn.2018.10.118
|
[45]
|
Jia, B., Zhang, X., Ma, N., et al. (2022) Comparison of Drug-Eluting Stent with Bare-Metal Stent in Patients with Symptomatic High-Grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial. JAMA Neurology, 79, 176-184. https://doi.org/10.1001/jamaneurol.2021.4804
|
[46]
|
Hassan, A.E., Mohammaden, M.H., Rabah, R.R., et al. (2020) Initial Experience with the Next-Generation Resolute Onyx Zotarolimus-Eluting Stent in Symptomatic Intracranial Atherosclerotic Disease. Frontiers in Neurology, 11, Article 570100. https://doi.org/10.3389/fneur.2020.570100
|
[47]
|
Stapleton, C.J., Chen, Y.F., Shallwani, H., et al. (2020) Submaximal Angioplasty for Symptomatic Intracranial Atherosclerotic Disease: A Meta-Analysis of Peri-Procedural and Long-Term Risk. Neurosurgery, 86, 755-762. https://doi.org/10.1093/neuros/nyz337
|
[48]
|
Seyedsaadat, S.M., Yolcu, Y.U., Neuhaus, A., et al. (2020) Submaximal Angioplasty in the Treatment of Patients with Symptomatic ICAD: A Systematic Review and Meta-Analysis. Journal of Neurointerventional Surgery, 12, 380-385. https://doi.org/10.1136/neurintsurg-2019-015451
|
[49]
|
Sun, X., Yang, M., Sun, D., et al. (2024) Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis (BASIS): Protocol of a Prospective, Multicentre, Randomised, Controlled Trial. Stroke and Vascular Neurology, 9, 66-74.
|
[50]
|
Li, G., Qiao, H., Lin, H., et al. (2022) Application of Drug-Coated Balloons for Intracranial Atherosclerosis Disease: A Systematic Review. Clinical Neurology and Neurosurgery, 213, Article ID: 107065. https://doi.org/10.1016/j.clineuro.2021.107065
|
[51]
|
Zhang, J., Zhang, X., Zhang, J., et al. (2020) Drug-Coated Balloon Dilation Compared with Conventional Stenting Angioplasty for Intracranial Atherosclerotic Disease. Neurosurgery, 87, 992-998. https://doi.org/10.1093/neuros/nyaa191
|
[52]
|
Liebeskind, D.S., Cotsonis, G.A., Saver, J.L., et al. (2011) Collaterals Dramatically Alter Stroke Risk in Intracranial Atherosclerosis. Annals of Neurology, 69, 963-974. https://doi.org/10.1002/ana.22354
|
[53]
|
Amin-Hanjani, S., Du, X., Rose-Finnell, L., et al. (2015) Hemodynamic Features of Symptomatic Vertebrobasilar Disease. Stroke, 46, 1850-1856. https://doi.org/10.1161/STROKEAHA.115.009215
|
[54]
|
Derdeyn, C.P., Fiorella, D., Lynn, M.J., et al. (2013) Mechanisms of Stroke after Intracranial Angioplasty and Stenting in the SAMMPRIS Trial. Neurosurgery, 72, 777-795. https://doi.org/10.1227/NEU.0b013e318286fdc8
|